Angela Zubel, chief development officer, Debiopharm, explains how AI-enabled site selection, patient allocation, and ...
In today’s ACT Brief, we examine how AI is shifting from pilot programs into daily development workflows, how a new adoption ...
Findings from the VA’s Diuretic Comparison Project show pragmatic trial designs can achieve strong provider participation when burden is minimized and patient care remains the primary focus.
Angela Zubel, chief development officer, Debiopharm, discusses why 2026 marks a shift from AI pilots to broader operational ...
The Digital Medicine Society (DiMe), through its Digital Health Measurement Collaborative Community (DATAcc), has launched a new educational resource designed to help sponsors and technology ...
This is the Applied Clinical Trials Brief —your fast track to the latest insights shaping clinical operations and drug development.
Miriam Dervan, founder & CEO of mdgroup, discusses how patient-centered strategies rooted in empathy and advocacy engagement ...
In today’s ACT Brief, we examine new data on regional variation in clinical trial risk, why patient experience must move from ...
Mike Wenger, chief innovation officer at CRIO, explains how AI can responsibly support data quality and monitoring with ...
Using KRIs or SDM, sponsors can detect a variety of emerging risks, including inadequate adverse-event reporting, protocol ...
Holly Leslie, vice president of services at Ledger Run, discusses how persistent payment friction, increasing administrative ...
In today’s ACT Brief, we cover a new real-world data collaboration aimed at scalable interoperability, how AI fits into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results